Among myeloid cells, Melanoma + Combi-ICI resulted in a significantly higher frequency and number of CD11b+ MHCII+ cells (Fig. 5I–J), suggesting increased antigen presentation and consistent with the findings of T cell expansion in the CNS. This evidence concerns the gene ITGAM and melanoma.